Refine by
Industries served
- Medical / Health Care
- Monitoring and Testing
- Agriculture
- Chemical & Pharmaceuticals
- Environmental
- University / Academia / Research
- Water and Wastewater
- Health and Safety
- Food and Beverage
- Energy
- Forestry & Wood
- Air and Climate
- Soil and Groundwater
- Mining
- Glassware
- Waste and Recycling
- Oil, Gas & Refineries
- Government
- Manufacturing, Other
Phenotyping Suppliers Near Eritrea
184 companies found
Premium
based inBurwell, UNITED KINGDOM
Delta-T offers a wide range of data loggers and sensors able to measure and record hydrological, meteorological and other environmental parameters. Our products provide direct measurements of the forces and effects that renewable energy and other ...
based inBentley DC, AUSTRALIA
Ozgene is one of the leading companies providing genetically modified mice for researchers around the world. We offer a full spectrum of pre-clinical capabilities from the development of mouse models through to breeding, characterisation and ...
The targeted transgenic mouse approach uses gene targeting by means of homologous recombination in embryonic stem (ES) cells. The transgene cDNA is knocked into a ‘safe habor’ locus in the mouse genome to generate transgenic mice with a ...
based inCharlestown, MASSACHUSETTS (USA)
We are a Boston-based company developing precision diagnostics for infectious diseases. Selux’s interdisciplinary team has expertise in microbiology, biochemistry, chemistry, engineering, software, and algorithm design and is buttressed by ...
The last development of Antimicrobial Susceptibility Testing (AST) was in 1969. We've changed that with our NGP technology—designed for this century's Integrated Health ...
based inNewton, MASSACHUSETTS (USA)
At 4D Path, we aim to revolutionize cancer diagnostics. Our patented, end-to-end statistical physics and tumor biology platform unveils hidden data and tissue phenotypes. This approach underpins biomarker typing and prognostication from H&E images, ...
based inRehovot, ISRAEL
Plant-DiTech was founded based on a technology developed by Professors Menachem Moshelion and Rony Wallach from the Hebrew University of Jerusalem - world renowned experts in plant stress physiology and soil and water science. Their aim was to use ...
Plantarray is a high-throughput, multi-sensor physiological phenotyping gravimetric-based platform. The system continuously and simultaneously measures the momentary-varying water flux in the Soil-Plant-Atmosphere (SPAC) for each ...
based inMarlborough, MASSACHUSETTS (USA)
At Akoya, we believe context is key. Our single-cell imaging solutions phenotype cells with spatial context to visualize how they organize and interact to influence disease progression and treatment response. The PhenoCycler™ (formerly CODEX®) and ...
Our PhenoImager® Instruments, powered by patented Multispectral Imaging (MSI) Technology, are the fastest quantitative digital pathology imaging platforms enabling rapid and accurate spatial phenotyping at scale. Pave the path ...
based inMidlothian, VIRGINIA (USA)
G3T is developing assets in cardio-metabolic, metabolic and cardiovascular diseases, such as non-alcoholic steatohepatitis (NASH), obesity, diabetes, atherosclerosis, etc. We define our assets as genetically validated drug targets. We partner with ...
We turn biological insights into novel drugs. We use artificial intelligence (AI) and machine learning (ML) to interrogate our data in an unbiased, hypothesis-free manner to drive drug development ...
based inBeverly, MASSACHUSETTS (USA)
Cellanyx is a growth stage emerging biotech advancing proprietary phenotypic (appearance and dynamics) biomarker tests based on Machine Vision and AI-driven analysis of live single tumor cells to improve risk-stratification and shared clinical ...
based inMontreal, QUEBEC (CANADA)
Optina’s Retinal Deep Phenotyping platform addresses the major challenges faced by the healthcare system related to an aging population. Recently, Optina was granted breakthrough device designation by the FDA for our first indication in Alzheimer’s ...
Our Retinal Deep PhenotypingTM platform combines a powerful hyperspectral camera, Optina-4CTM, and AI-driven technology, awAIrTM system, which can identify subtle changes that are invisible to any other current technologies. The retina is a ...
based inBoston, MASSACHUSETTS (USA)
Genomic data is becoming increasingly important in modern healthcare as well as in biological research. The size and complexity of this data, however, makes it almost impossible for many experts to get the most out of this data. Frameshift Genomics ...
Mosaic is a collaborative platform for organizing, visualizing, and understanding genomic ...
based inSchlieren, SWITZERLAND
Elthera AG is a Swiss biopharmaceutical company founded in 2016 by experienced Pharma and Biotech executives with the goal of developing proprietary, first-in-class oncology drugs using a personalized health care approach. Elthera AG is developing ...
L1CAM expression increases the malignancy of these tumors by promoting cellular proliferation, metastatic spread, tumor angiogenesis, and resistance to chemotherapy. Accordingly, L1CAM-positive tumors show a highly malignant and invasive ...
based inBoston, MASSACHUSETTS (USA)
SOPHiA GENETICS is the creator of a global data-sharing network – we work with customers from over 790 institutions in over 70 countries. Our network advances data-driven medicine to improve health outcomes and economics worldwide. We offer a ...
Most rare and inherited diseases have a neurological component, likely because more than 80% of human genes are expressed in the brain.1 Neurological disorders are multifactorial and heterogeneous, meaning that their genetic basis is often poorly ...
based inLeiden, NETHERLANDS
We are a global leader in human 3D disease modeling using our organ-on-a-chip platform, the OrganoPlate. We work with top pharmaceutical and biotech companies to develop novel therapies against unsolved diseases. Our human tissue & disease modeling ...
Capture and understand human disease biology in vitro. The key to unlocking effective therapies for the unsolved diseases of our times is a deep understanding of human disease biology. To this end, MIMETAS aims to capture the essence of diseases in ...
based inWroclaw, POLAND
GlucoActive is a seed-stage medical startup focused on developing non-invasive glucose measurement technology using optical methods, specifically spectroscopy. Established in 2019, we are based in Wroclaw, Poland, and proudly employ a team of 30 ...
based inGlasgow, UNITED KINGDOM
Our mission is to enhance decision making within R&D by leveraging Digital Pathology to deliver robust data and actionable insights. OracleBio is a global leader in quantitative digital pathology, providing image analysis services to Pharma and ...
Adding value to Immuno-Oncology studies with Quantitative Digital Pathology. Quantitative Digital Pathology provides deep insights into the tumor microenvironment (TME), a knowledge which is crucial for understanding the mechanism of action of new ...
based inMadison, WISCONSIN (USA)
InvivoSciences, Inc. (IVS) is a precision medicine company personalizing the drug development process by introducing patient-derived and gene-edited human samples, including 3D engineered microtissues. Our unique integration of cell & tissue ...
Human engineered tissue (EHT)-based high content analysis can be applied to drug discovery projects at their compound screening and lead optimization stage. Mass-produced human engineered tissues will recapitulate physiological functions of native ...
based inBangalore, INDIA
Cellworks’ mission is to serve patients through advances in personalized medicine that significantly improve treatment success. We achieve better outcomes by predicting a successful match between patients and drug therapies – their Therapy Response ...
The Cellworks Platform biosimulates how a patient’s unique cancer will respond to therapies prior to treatment and identifies novel drug combinations for treatment-refractory patients. Therapy biosimulation is the ability to predict the ...
based inKontich, BELGIUM
Fluidda was founded in 2005, focusing on Computational Fluid Dynamics (CFD), a discipline used in the design of aircraft wings. Image processing of CT scans and flow simulations on patient-specific 3D models are combined to provide a unique ...
based inNewcastle Upon Tyne, UNITED KINGDOM
Our mission at Alcyomics is to provide novel solutions for the assessment of safety and efficacy of pharmaceuticals, cosmetics and chemicals. As a service provider Alcyomics aspires to take the lead in providing unique screening services enabling ...
Assessment of immune activation: Alcyomics has a wide range of cell phenotypic services for your research needs, to benefit both drug discovery and validation. With our in-house state-of-the-art instrumentation, we can analyse and ...
based inSchlieren, SWITZERLAND
The biotech-company EraCal Therapeutics Ltd. is a spin-off from the University of Zurich and Harvard University. The company is privately held by a biotech-specialized investor base incl. BERNINA BioInvest, Redalpine, and UZH Life Sciences ...
EraCal’s platform enables unbiased and large-scale in vivo drug discovery in zebrafish larvae. The journal Science Advances published part of EraCal’s translational proof of concept. Such phenotypic strategies are ...